Rash News and Research

RSS

Recombinant adjuvanted zoster vaccination associated with lower risk of COVID-19 diagnosis and hospitalization

A new study suggests that RZV may elicit durable innate immune responses in the elderly conferring heterologous protection against COVID-19. .

30 Dec 2021

Which population does extreme heat affect the most?

In this interview, we speak to Professor Gregory Wellenius about his latest research into extreme heat and how it may affect younger adults more than older adults.

16 Dec 2021

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

A drug combination can safely prevent transplanted stem cells, known as a graft, from attacking the recipient's body, allowing them to develop into healthy new blood and immune cells, a new study shows.

14 Dec 2021

UVA researchers uncover common link between lupus and macular degeneration

University of Virginia School of Medicine researchers have made a discovery linking lupus, a potentially debilitating autoimmune disorder, and macular degeneration, a leading cause of blindness.

9 Dec 2021

An analysis of risk factors and symptom presentation among groups at risk for SARS-CoV-2 infection

The study, published on the pre-print server medRxiv*, analyzed the specific linkages between the COVID-19 patients belonging to the three risk groups with the overall COVID-19 patients and compared symptoms between and within the risk groups.

6 Dec 2021

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

A new case study on the report of multisystem inflammatory syndrome (MISC) in a 22-year-old woman in South Korea after vaccination.

5 Dec 2021

Exposure to Chikungunya may offer partial cross-protection against Mayaro virus

A study conducted at the University of São Paulo (USP) in Brazil suggests people previously infected by Chikungunya virus may develop partial immunity to Mayaro virus.

4 Dec 2021

Safety and immunogenicity of COVID-19 peptide vaccine

In a study published in Nature, researchers from University Hospital Tübingen have been investigating the results from a Phase I trial for a new vaccine against SARS-CoV-2 variants.

25 Nov 2021

Antiretroviral drugs detected in drinking water

Years ago, there was a time that kids from a rural village in South Africa still wanted to swim in the rivers nearby. But when they got out of the water, those with sensitive skins would have the worst rash ever, says Prof Philiswa Nomngongo.

18 Nov 2021

CDC scientists confirm imported monkeypox case in Maryland

Scientists at the Centers for Disease Control and Prevention (CDC) are collaborating with the Maryland Department of Health and other health partners to investigate a case of monkeypox in a traveler who returned to the United States from Nigeria.

17 Nov 2021

Combination treatment improves overall survival for melanoma patients with brain metastases

Combination treatment with immune checkpoint inhibitors nivolumab and ipilimumab demonstrates overall survival for patients with melanoma that has spread to the brain, according to Phase II study results published today in The Lancet Oncology by researchers from The University of Texas MD Anderson Cancer Center.

11 Nov 2021

The autoantibody profile in COVID-19 patients with MIS-C

A new study assessed the presence of autoantibodies against autoantigens associated with known autoimmune diseases in patients with COVID-19.

10 Nov 2021

Factors predicting cognitive symptoms in long COVID

The researchers focused on finding risk factors for long-term symptom occurrence and severity, with special attention to cognitive impairment.

1 Nov 2021

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

Kawasaki disease (KD) is rare, with fewer than 6,000 diagnosed cases per year in the United States. It is most common in infants and young children and causes inflammation in the walls of some blood vessels in the body.

27 Oct 2021

‘Down to my last diaper’: The anxiety of parenting in poverty

For parents living in poverty, "diaper math" is a familiar and distressingly pressing daily calculation. Babies in the U.S. go through six to 10 disposable diapers a day, at an average cost of $70 to $80 a month. Name-brand diapers with high-end absorption sell for as much as a half a dollar each, and can result in upwards of $120 a month in expenses.

22 Oct 2021

Rash News and Research

Recombinant adjuvanted zoster vaccination associated with lower risk of COVID-19 diagnosis and hospitalization

Which population does extreme heat affect the most?

New drug combination may prevent GvHD after stem cell transplantation for blood cancers

UVA researchers uncover common link between lupus and macular degeneration

An analysis of risk factors and symptom presentation among groups at risk for SARS-CoV-2 infection

A case of post-vaccination MIS in an adult without prior SARS-CoV-2 infection

Exposure to Chikungunya may offer partial cross-protection against Mayaro virus

Safety and immunogenicity of COVID-19 peptide vaccine

Antiretroviral drugs detected in drinking water

CDC scientists confirm imported monkeypox case in Maryland

Combination treatment improves overall survival for melanoma patients with brain metastases

The autoantibody profile in COVID-19 patients with MIS-C

Factors predicting cognitive symptoms in long COVID

Studies test intravenous immunoglobulin for treatment of Kawasaki disease and MIS-C

‘Down to my last diaper’: The anxiety of parenting in poverty

Scientists search for cause of mysterious covid-related inflammation in children

Phase 2 study shows safety and immunogenicity of SARS-CoV-2 recombinant protein vaccine

Drug developed at Duke is approved by FDA as only therapy for congenital athymia

Gene expression changes during acute SARS-CoV-2 infection may decide long-COVID symptoms

Research reveals key differences between childhood and adult chronic spontaneous urticaria

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News